Ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis against HIV infection, identifies patterns of medication taking that may lead to risk of prophylactic failure in near real-time.
Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled ...